Instead, five protein markers - ER, PR, HER2, Cytokeratin 5 (CK5) and epidermal growth factor receptor-1 (EGFR) - can serve as surrogates to classify breast cancers into subtypes analogous to those defined by gene profiling. The gene discussed is EGFR; the disease is breast carcinoma.